Fürüzan KÖKTÜRK, Emin TAMER, Seray KÜLCÜ ÇAKMAK, Ferda ARTÜZ, Emrah YILMAZ

Evaluation of serum uric acid levels in psoriasis vulgaris

Background/aim: Psoriasis has been accepted as a systemic disease and it is known to be associated with various disorders including metabolic syndrome. High serum uric acid levels are also associated with the components of metabolic syndrome. In this study, we aimed to determine serum uric acid levels in patients with psoriasis and the association of uric acid levels with disease activity by taking the presence of metabolic syndrome criteria into account, since it is one of the most important factors that affect serum uric acid levels. Materials and methods: In this cross-sectional study, we evaluated 70 psoriasis patients and 70 healthy individuals who were matched with the patients according to the presence of metabolic syndrome. We evaluated the demographic features, levels of serum uric acid, Psoriasis Area Severity Index (PASI) scores, presence of psoriatic arthritis, nail involvement, and metabolic syndrome criteria of the patients. Results: Serum uric acid levels of psoriasis patients were significantly higher than those of controls. There was a positive correlation between PASI scores and serum uric acid levels of the patients. Conclusion: As hyperuricemia had a close relationship with psoriasis and PASI scores, we suggest monitoring patients with psoriasis for serum uric acid levels during treatment and follow-up.

PDF

___

1. Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL, Gülekon A. Psoriasis ve benzeri dermatozlar. In: Tüzün Y, Gürer MA, Serveroğlu S, Sungur O, Aksungur LA, editors. Dermatoloji 3. Baskı. İstanbul, Turkey: Nobel Tıp Kitabevi; 2008. pp. 745-756 (in Turkish).
2. Champe PC, Harvey RA. Lippincotts Illustrated Reviews: Biochemistry. Philadelphia PA, USA: Lippincott Company; 1994.
3. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and AfricanAmericans. The atherosclerosis risk in communities baseline study. Diabetes Care 1996; 19: 414-418.
4. Yoo TW, Sung KC, Shin HS. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
5. Parodi A, Aste N, Calvieri C, Cantoresi F, Carlesimo M, Fabbri P, Filosa G, Galluccio A, Lisi P, Micali G et al. Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population. Am J Clin Dermatol 2014; 15: 371-377.
6. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20: 416-422.
7. Eroglu S, Sade L, Yildirir A, Yildirir A, Demir O, Bozbas H, Muderrisoglu H. Serum levels of c-reaktive protein and uric acid in patients with cardiac syndrome X. Acta Cardiol 2009; 64: 207-211.
8. Kwon HH, Kwon IH, Choi JW. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol 2011; 36: 473-478.
9. Isha V, Jain K, Harbans L. C-reactive protein and uric acid levels in patients with psoriasis. Ind J Clin Biochem 2011; 26: 309-311.
10. Gisondi P, Targher G, Cagalli A. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol 2014; 70: 127-130.
11. Ataseven A, Kesli R, Kurtipek GS. Assessment of lipocalin 2, clusterin, soluble TNF receptor-1, IL-6, homocysteine and uric acid levels in patients with psoriasis. Dis Markers 2014; 2014: 541709.
12. Grzybowski G, Fafara I, Zaba R, Wierusz-Wysocka B. Evaluation of glucose, insulin, c-peptide, uric acid serum levels in patients with psoriasis. Pol Merkur Lekarski 2001; 11: 495- 498.
13. Yavuzer K. Psoriyazis Hastalarında Serum Ürik Asit Düzeylerinde Hastalık Şiddetinin Değerlendirilmesinin Yeri. Ankara, Turkey: SB Ankara Eğitim ve Araştırma Hastanesi Deri ve Zührevi Hastalıklar Kliniği; 2005 (in Turkish).
14. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.